Two other biotechs undertaking secondary offerings today: Arrowhead Research (ARWR) off 6.5%...

|About: Arrowhead Pharmaceuticals (ARWR)|By:, SA News Editor

Two other biotechs undertaking secondary offerings today: Arrowhead Research (ARWR) off 6.5% premarket - and Anthera Pharmaceuticals (ANTH) - off 10% premarket. (Arrowhead PR). (Anthera PR). (BG Medicine earlier).